News

Lower DMPA dose provides comparable efficacy, tolerability in adolescents

Publish date: April 18, 2015

 

AT THE NASPAG ANNUAL MEETING

References

This study was funded by a Society of Family Planning research grant and a Clinical and Translational Science Awards grant. Dr. Bonny reported having no disclosures.

sworcester@frontlinemedcom.com

Pages

Recommended Reading

Poor diet hampers children’s cardiovascular health
MDedge Endocrinology
FDA approves cholic acid for rare metabolic conditions
MDedge Endocrinology
Long-term endocrine effects common after reduced-intensity chemotherapy in children
MDedge Endocrinology
Pediatric BMI improves with motivational interviewing
MDedge Endocrinology
Children’s fast food consumption dwindling
MDedge Endocrinology
High testosterone, no growth benefit for boys treated with letrozole
MDedge Endocrinology
No growth hormone/cancer link in kids without malignancy risks
MDedge Endocrinology
Estrogen assays need to improve
MDedge Endocrinology
Controversial technique appeals to women with mitochondrial diseases
MDedge Endocrinology
Gastric emptying more rapid in adolescents with type 1 diabetes
MDedge Endocrinology